calendar

4 catalysts · 4 approval

next 91 dayslessmore

MonWedFri

view

sort

Week of Aug 27, 2012

4

Aug 30, 2012approval5092d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

Aug 30, 2012approval5092d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: INJECTABLE. Route: INJECTION

Aug 30, 2012approval5092d agoSANDIMMUNE (CYCLOSPORINE) — FDA approvalRestasis

Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

Aug 30, 2012approval5092d agoLINZESS (LINACLOTIDE) — FDA approvallinaclotide

Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL

$NVS156.33+1.37%

$ABBV246.04+0.89%

$NVS156.33+1.37%